This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, S J Articles by Jay, G Search for Related Content PubMed PubMed Citation Articles by Kim, S J Articles by Jay, G

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 October; 11(10): 5222-5228

Overexpression of transforming growth factor-beta in transgenic mice carrying the human T-cell lymphotropic virus type I tax gene.

Laboratory of Chemoprevention, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

Human T-cell lymphotropic virus type I (HTLV-I) has been associated with an adult form of T-cell leukemia as well as tropical spastic paraparesis, a neurodegenerative disease. Adult T-cell leukemia patients express high levels of the type 1 isoform of transforming growth factor-beta (TGF-beta 1), which is mediated by the effects of the HTLV-I Tax transactivator protein on the TGF-beta 1 promoter. To understand further the regulation of TGF-beta 1 expression by Tax, we examined its expression in transgenic mice carrying the HTLV-I tax gene. We show that tumors from these mice and other tissues, such as submaxillary glands and skeletal muscle, which express high levels of tax mRNA selectively express high levels of TGF-beta 1 mRNA and protein. Moreover, TGF-beta 1 significantly stimulated the incorporation of tritiated thymidine into one of three cell lines derived from neurofibromas of tax-transgenic mice, which suggests that the excessive production of TGF-beta 1 may play a role in tumorigenesis and that these mice may serve as a useful model for studying the biological effects of TGF-beta in vivo.

This article has been cited by other articles:

• Jung, K.-J., Dasgupta, A., Huang, K., Jeong, S.-J., Pise-Masison, C., Gurova, K. V., Brady, J. N. (2008). Small-Molecule Inhibitor Which Reactivates p53 in Human T-Cell Leukemia Virus Type 1-Transformed Cells. J. Virol. 82: 8537-8547 [Abstract] [Full Text]  
• Kwon, H., Ogle, L., Benitez, B., Bohuslav, J., Montano, M., Felsher, D. W., Greene, W. C. (2005). Lethal Cutaneous Disease in Transgenic Mice Conditionally Expressing Type I Human T Cell Leukemia Virus Tax. J. Biol. Chem. 280: 35713-35722 [Abstract] [Full Text]  
• Lee, H.-J., Lee, J. K., Miyake, S., Kim, S.-J. (2004). A Novel E1A-like Inhibitor of Differentiation (EID) Family Member, EID-2, Suppresses Transforming Growth Factor (TGF)-{beta} Signaling by Blocking TGF-{beta}-induced Formation of Smad3-Smad4 Complexes. J. Biol. Chem. 279: 2666-2672 [Abstract] [Full Text]  
• Lee, D. K., Kim, B.-C., Kim, I. Y., Cho, E.-a., Satterwhite, D. J., Kim, S.-J. (2002). The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-beta Signaling by Blocking Binding of the Smad Complex to Its Target Sequence. J. Biol. Chem. 277: 38557-38564 [Abstract] [Full Text]  
• Lee, D. K., Kim, B.-C., Brady, J. N., Jeang, K.-T., Kim, S.-J. (2002). Human T-cell Lymphotropic Virus Type 1 Tax Inhibits Transforming Growth Factor-beta Signaling by Blocking the Association of Smad Proteins with Smad-binding Element. J. Biol. Chem. 277: 33766-33775 [Abstract] [Full Text]  
• Kanzaki, T., Tamura, K., Takahashi, K., Saito, Y., Akikusa, B., Oohashi, H., Kasayuki, N., Ueda, M., Morisaki, N. (1995). In Vivo Effect of TGF-ß1 : Enhanced Intimal Thickening by Administration of TGF-ß1 in Rabbit Arteries Injured With a Balloon Catheter. Arterioscler. Thromb. Vasc. Bio. 15: 1951-1957 [Abstract] [Full Text]